Dr. James Robinson, head of the Cell Signaling & Tumorigenesis lab at The Hormel Institute, and Dr. Edward “Ted” Hinchcliffe, head of the Cellular Dynamics lab at The Hormel Institute, attended the Jiler Professors and Fellows Conference meeting last month.
The Jiler Professors & Fellows Conference is a biennial conference sponsored by the American Cancer Society that brings together top researchers who are past or present recipients of particular grants from the American Cancer Society. The conference is intended to be an event for exchanging ideas and facilitating collaboration between the best and brightest minds in cancer research.
Dr. Robinson currently has a new American Cancer Society Research Scholar Grant to fund innovative melanoma research. Skin cancer is the most common type of cancer and melanoma is the most dangerous form of skin cancer. Robinson’s research aims to find the core mechanisms involved in melanoma’s resistance to two specific cancer drugs.
Dr. Hinchcliffe was formerly awarded an American Cancer Society post-doctoral award and Research Scholar Award.
The inclusion of The Hormel Institute's research in the Jiler Professors & Fellows Conference dinner emphasizes growing support and collaboration with ACS. Last year, Dr. Otis Webb Brawley, Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society and other ACS leaders, met with The Hormel Institute's Drs. Zigang Dong, Ann Bode and Gail Dennison to exchange ideas and grow collaborative support.
"We are thankful to the American Cancer Society for their support as funding, and working with other researchers, is extremely important," said Dr. Robinson. “Research and sharing information is the only way we can find new and better ways to fight cancer.”